Xilio Therapeutics (XLO) Return on Capital Employed (QoQ) (2022 - 2026)
Xilio Therapeutics (XLO) Return on Capital Employed (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Xilio Therapeutics | 145.98 Mn | -4.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,138.00 |
| Dec 31, 2025 | 884.00 |
| Sep 30, 2025 | 2,983.00 |
| Jun 30, 2025 | 5,681.00 |
| Mar 31, 2025 | -1,039.00 |
| Dec 31, 2024 | 1,426.00 |
| Sep 30, 2024 | -491.00 |
| Jun 30, 2024 | 3,970.00 |
| Mar 31, 2024 | -3,378.00 |
| Dec 31, 2023 | -2,465.00 |
| Sep 30, 2023 | -2,186.00 |
| Jun 30, 2023 | -1,782.00 |
| Mar 31, 2023 | -1,369.00 |
| Dec 31, 2022 | -1,343.00 |
| Sep 30, 2022 | -871.00 |
| Jun 30, 2022 | -707.00 |
| Mar 31, 2022 | 702.00 |